The National Health Commission said in a notice released on Tuesday that it has recently learned that some medical ...

Higher education appeared to protect against tau accumulation during the amyloid-negative stages of Alzheimer's disease but ...

Alzheimer's disease, which is a neurodegenerative disease that affects ... The fastest growth in older populations is ...

Eli Lilly has chalked up another regulatory approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest pharma market. The National Medical ...

The 43,000 sq m facility – roughly the size of six football fields – features spaces that replicate familiar settings like a ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment INDIANAPOLIS, ...

The facility gives residents more choice and autonomy in daily living. Read more at straitstimes.com. Read more at ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms start is 39.